EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance

Mohammed Kaleem, Lubna Azmi, Naiyer Shahzad, Murtada Taha, Shiv Kumar, Md Ali Mujtaba, Abdulaziz Ali H Hazazi, Asaad Kayali

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04217-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Mohammed Kaleem und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: Deanship of Scientific Research at Northern Border University, Arar, KSA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer progression is governed by a dynamic interplay of genetic, epigenetic, and molecular mechanisms that regulate tumor initiation, growth, metastasis, and therapy resistance. This review highlights key molecular pathways involved in oncogenesis, focusing on genetic alterations (mutations, amplifications, and translocations) in oncogenes (RAS and MYC) and tumor suppressor genes (TP53 and PTEN). Additionally, genomic instability, resulting from defective DNA repair mechanisms like mismatch repair and homologous recombination (HR), is identified as a critical factor contributing to tumor heterogeneity and clonal evolution. Epigenetic modifications, including DNA methylation, histone acetylation, and non-coding RNA regulation, further remodel chromatin structure and modulate gene expression, influencing tumor initiation, growth, metastasis, and response to treatment. Post-translational modifications, such as the attachment of a Small Ubiquitin-like Modifier (SUMO) to a target protein and ubiquitination, further influence autophagy, apoptosis, and cellular plasticity, enabling cancer cells to survive therapeutic stress. Cutting-edge technologies such as CRISPR-Cas9-mediated epigenome editing and single-cell RNA sequencing have opened new doors to understanding cellular diversity and regulatory networks in cancer. The review further examines the tumor microenvironment, including stromal remodeling, immune evasion, and hypoxia-driven signaling pathways, which are critical modulators of tumor progression and drug resistance to treatment. By integrating molecular, genetic, and epigenetic perspectives, this study underscores the crucial need for innovative, targeted therapeutic approaches to address the complexity and adaptability of cancer, thereby paving the way for more effective treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticNeoplasmsAntineoplastic AgentsHumansCarcinogenesisGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmDisease ProgressionTumor MicroenvironmentSingle-Cell Gene Expression AnalysisProtein Processing, Post-TranslationalTumor EscapeMolecular Targeted TherapyPrecision Medicine

Stichwörter der Autor:innen

EpigeneticMetastasisMicroenvironmentMolecular mechanismsOncogeneTumor progression

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India.
  • Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Science, University of Lucknow, Uttar Pradesh, Lucknow, India.
  • Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Clinical Laboratory Science, Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia.
  • School of Biomedical Engineering, Indian Institute of Technology (BHU) Varanasi, Uttar Pradesh, Varanasi, India.
  • Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Arar, Saudi Arabia. M.Mujtaba@nbu.edu.sa.

Förderung

  • Deanship of Scientific Research at Northern Border University, Arar, KSA

Zitieren

APA

Kaleem, M., Azmi, L., Shahzad, N., Taha, M., Kumar, S., Mujtaba, M. A., Hazazi, A. A. H., & Kayali, A. (2025). Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04217-5

Vancouver

Kaleem M, Azmi L, Shahzad N, Taha M, Kumar S, Mujtaba MA, et al. Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04217-5

BibTeX
@article{Kaleem2025,
  author = {Kaleem, Mohammed and Azmi, Lubna and Shahzad, Naiyer and Taha, Murtada and Kumar, Shiv and Mujtaba, Md Ali and Hazazi, Abdulaziz Ali H and Kayali, Asaad},
  title = {Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04217-5}
}
Kostenlos starten →